PI-273 |
Catalog No.GC39155 |
PI-273은 IC50이 0.47μM인 최초의 가역적이고 특이적인 포스파티딜이노시톨 4-키나제(PI4KIIα) 억제제입니다. PI-273은 유방암 세포 증식을 억제하고 세포 주기를 차단하며 세포 사멸을 유도할 수 있습니다.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 925069-34-7
Sample solution is provided at 25 µL, 10mM.
PI-273 is a first reversibly and specific phosphatidylinositol 4-kinase (PI4KIIα) inhibitor with an IC50 of 0.47 μM. PI-273 can inhibit breast cancer cell proliferation, block the cell cycle and induce cell apoptosis[1].
[1]. Li J, et al. PI-273, a Substrate-Competitive, Specific Small-Molecule Inhibitor of PI4KIIα, Inhibits the Growth of Breast Cancer Cells. Cancer Res. 2017 Nov 15;77(22):6253-6266.
Average Rating: 5
(Based on Reviews and 2 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *